Market Overview:
The global bacteriophages therapy service market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bacterial infections, rising demand for novel antimicrobial drugs, and growing awareness about phage therapy. Based on type, the global bacteriophages therapy service market can be segmented into lytic and lysogenic. Lytic bacteriophages are more commonly used for therapeutic purposes as they are able to kill bacteria quickly. Lysogenic bacteriophages are less effective against bacteria but they have the ability to insert their DNA into the host cells, which makes them useful for gene editing applications. Based on application, the global bacteriophages therapy service market can be segmented into diagnostic, antimicrobial drug discovery, and veterinary medicines. Of these applications, diagnostic is expected to witness highest growth during the forecast period owing to increasing demand for rapid diagnosis of bacterial infections. Region-wise, North America is expected to lead the global bacteriophages therapy service market during the forecast period followed by Europe.
Product Definition:
Bacteriophages therapy service is a treatment for bacterial infections that uses bacteriophages, viruses that specifically infect bacteria. The therapy service is important because it can treat infections that are resistant to traditional antibiotics.
Lytic:
The lytic cycle is the final phase of the life cycle of a bacteriophage. It is used to lysis (opening) bacterial cells so that the contents can be released and new phage particles can form. The process involves three steps, namely, penetration, infection, and release or lysis.
lysogenic:
Lysogenic Bacteriophages (KP) are naturally occurring viruses that parasitize bacteria. They have a circular DNA genome which is derived from the bacterial chromosome. The viral genes are expressed in the bacterium and they replicate within it. These lysogenic viruses do not harm the host bacteria but instead help them to grow and multiply by producing end products that benefit the host as well as parasite.
Application Insights:
The global market is segmented by application into diagnostic, antimicrobial drug discovery and veterinary medicines. The diagnostic segment dominated the overall industry in terms of revenue in 2017 owing to the rising demand for phage therapy as a tool for bacterial detection and identification. Moreover, increasing research activities pertaining to development of novel therapeutic applications is expected to drive growth over the forecast period.
The antimicrobial drug discovery segment held a significant share in 2018 and is anticipated to grow at lucrative CAGR during the forecast period due largely to extensive R&D investments undertaken by major companies such as Intrexon Corporation (U.S.), Merck KGaA (Germany), Pfizer Inc., sanofi pasteur LLC (France) etc.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of biopharmaceutical companies engaged in developing and commercializing therapeutics using these phages. The region is expected to maintain its dominance over the forecast period as well owing to factors such as favorable government initiatives, increasing R&D investments by domestic companies, and growing focus on novel therapies for treatment of infections.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as rising healthcare expenditure by governments along with an increase in spending on pharmaceuticals and antibiotics production resulting from low cost raw materials availability. In addition, increasing incidence of hospital-acquired infections due to lack of hygiene & safety standards at medical facilities are some other factors that can be attributed for rapid growth rate observed in this region.
Growth Factors:
- Increasing incidence of bacterial infections: The increasing incidence of bacterial infections is one of the key growth drivers for the bacteriophages therapy service market. According to a study by the Centers for Disease Control and Prevention (CDC), every year, about 2 million people in the U.S. develop serious antibiotic-resistant infections, and at least 23,000 people die as a result of these infections. This growing concern over antibiotic-resistant bacteria is expected to drive demand for bacteriophages therapy services in the coming years.
- Rising awareness about benefits of bacteriophages therapy: There is a growing awareness among healthcare professionals and patients about the benefits of using bacteriophages therapy as an alternative or adjunct treatment option for various types of bacterial infections. This is likely to boost demand for bacteriophage therapies in the coming years.
- Technological advancements in phage technology: The technological advancements in phage technology are another major factor driving growth prospects for this market segment over the forecast period 2017–2025 . These advancements are helping researchers develop more effective and targeted phage therapies that can be used to treat a wider range of bacterial pathogens than ever before . This is likely to spur demand from both healthcare providers and patients alike over this period .
- around
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacteriophages Therapy Service Market Research Report
By Type
Lytic, lysogenic
By Application
Diagnostic, Antimicrobial Drug Discovery, Veterinary medicines
By Companies
AmpliPhi Bioscience Corporation, EnBiotix, iNtoDEWorld, Phage International, Fixed Phage limited, Locus Bioscience, Pherecydes Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Bacteriophages Therapy Service Market Report Segments:
The global Bacteriophages Therapy Service market is segmented on the basis of:
Types
Lytic, lysogenic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic, Antimicrobial Drug Discovery, Veterinary medicines
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AmpliPhi Bioscience Corporation
- EnBiotix
- iNtoDEWorld
- Phage International
- Fixed Phage limited
- Locus Bioscience
- Pherecydes Pharma
Highlights of The Bacteriophages Therapy Service Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lytic
- lysogenic
- By Application:
- Diagnostic
- Antimicrobial Drug Discovery
- Veterinary medicines
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacteriophages Therapy Service Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacteriophages Therapy Service is a clinical service that uses phages to treat bacterial infections.
Some of the key players operating in the bacteriophages therapy service market are AmpliPhi Bioscience Corporation, EnBiotix, iNtoDEWorld, Phage International, Fixed Phage limited, Locus Bioscience, Pherecydes Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacteriophages Therapy Service Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bacteriophages Therapy Service Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bacteriophages Therapy Service Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bacteriophages Therapy Service Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bacteriophages Therapy Service Market Size & Forecast, 2018-2028
4.5.1 Bacteriophages Therapy Service Market Size and Y-o-Y Growth
4.5.2 Bacteriophages Therapy Service Market Absolute $ Opportunity
Chapter 5 Global Bacteriophages Therapy Service Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bacteriophages Therapy Service Market Size Forecast by Type
5.2.1 Lytic
5.2.2 lysogenic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bacteriophages Therapy Service Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bacteriophages Therapy Service Market Size Forecast by Applications
6.2.1 Diagnostic
6.2.2 Antimicrobial Drug Discovery
6.2.3 Veterinary medicines
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacteriophages Therapy Service Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacteriophages Therapy Service Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bacteriophages Therapy Service Analysis and Forecast
9.1 Introduction
9.2 North America Bacteriophages Therapy Service Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bacteriophages Therapy Service Market Size Forecast by Type
9.6.1 Lytic
9.6.2 lysogenic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bacteriophages Therapy Service Market Size Forecast by Applications
9.10.1 Diagnostic
9.10.2 Antimicrobial Drug Discovery
9.10.3 Veterinary medicines
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bacteriophages Therapy Service Analysis and Forecast
10.1 Introduction
10.2 Europe Bacteriophages Therapy Service Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bacteriophages Therapy Service Market Size Forecast by Type
10.6.1 Lytic
10.6.2 lysogenic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bacteriophages Therapy Service Market Size Forecast by Applications
10.10.1 Diagnostic
10.10.2 Antimicrobial Drug Discovery
10.10.3 Veterinary medicines
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bacteriophages Therapy Service Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bacteriophages Therapy Service Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bacteriophages Therapy Service Market Size Forecast by Type
11.6.1 Lytic
11.6.2 lysogenic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bacteriophages Therapy Service Market Size Forecast by Applications
11.10.1 Diagnostic
11.10.2 Antimicrobial Drug Discovery
11.10.3 Veterinary medicines
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bacteriophages Therapy Service Analysis and Forecast
12.1 Introduction
12.2 Latin America Bacteriophages Therapy Service Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bacteriophages Therapy Service Market Size Forecast by Type
12.6.1 Lytic
12.6.2 lysogenic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bacteriophages Therapy Service Market Size Forecast by Applications
12.10.1 Diagnostic
12.10.2 Antimicrobial Drug Discovery
12.10.3 Veterinary medicines
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bacteriophages Therapy Service Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bacteriophages Therapy Service Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bacteriophages Therapy Service Market Size Forecast by Type
13.6.1 Lytic
13.6.2 lysogenic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bacteriophages Therapy Service Market Size Forecast by Applications
13.10.1 Diagnostic
13.10.2 Antimicrobial Drug Discovery
13.10.3 Veterinary medicines
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacteriophages Therapy Service Market: Competitive Dashboard
14.2 Global Bacteriophages Therapy Service Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AmpliPhi Bioscience Corporation
14.3.2 EnBiotix
14.3.3 iNtoDEWorld
14.3.4 Phage International
14.3.5 Fixed Phage limited
14.3.6 Locus Bioscience
14.3.7 Pherecydes Pharma
